PET/CT: Improved Confidence in Imaging

Slides:



Advertisements
Similar presentations
Marketing PET in Radiation Treatment Planning
Advertisements

Helical CT Screening for Lung Cancer at Advanced Radiology Consultants
CLINICAL USE OF SPECT-CT IN BREAST & PROSTATE CANCERS
What are PET basics?.
Yasir Rudha, MD; Amr Aref, MD; Paul Chuba, MD; Kevin O’Brien, MD
Radiologic Imaging Defines the local extent of a tumor Can be used to stage malignant disease Aids in the diagnosis Monitoring tumor changes after treatment.
STAGING OF BRONCHOGENIC CA NSCLC STAGING TNM CLASSFICATION Adenocarcinoma Squamous cell carcinoma Large cell carcinoma T – Primary tumor N – Regional.
Diagnosis and Palliation for lung Cancer
PET/CT in Oncology George Segall, M.D. Stanford University.
FDG-PET/CT PATTERNS AND PREVALENCE OF PERITONEAL SPREAD IN OVARIAN CANCER Srour SF 1, Bar-Shalom R 2 Srour SF 1, Bar-Shalom R 2 1 Department of Diagnostic.
The Thyroid Incidentaloma
Objective Comparison of direct real-time endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA), PET, CT for detection of mediastinal.
Surgical principle of Management of Tumors M.A.Kubtan, MD – FRCS 1 st Lecture 1M.A.Kubtan.
Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital.
Metastatic involvement (M) M0 - No metastases M1 - Metastases present.
PHYSICS IN NUCLEAR MEDICINE: QUANTITAITVE SPECT AND CLINICAL APPLICATIONS Kathy Willowson Department of Nuclear Medicine, Royal North Shore Hospital University.
Brain Scan Imaging MRI, CAT, PET Imaging Interpreting Functions of the Brain through Imaging – Activity Case Study – Professional Sports and Head Trauma.
Application of Positron Emission Tomography ( PET ) in Colorectal Cancer Dr Chan Wai Keung Department of Surgery Ruttonjee and Tang Shiu Kin Hospitals.
Clinical Utility of Combidex in Various Cancers
Radiology Research at BUMC Jorge Soto, MD Vice Chair Research, Radiology Associate Professor, Radiology 12/19/07.
AN INTRODUCTION TO PET-CT SCANNING Ray Murphy Chair – MCCN Partnership Group.
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Breast Cancer Early detection of disease Precise Staging.
18 F-FET PET Compared with 18 F- FDG PET and CT in Patients with Head and Neck Cancer Present by Intern 羅穎駿 Journal of Nuclear Medicine Vol. 47 No
MEDICAL IMAGING.
Update on 18 F-Fluorodeoxyglucose/Positron Emission Tomography and Positron Emission Tomography/ Computed Tomography Imaging of Squamous Head and Neck.
MedPix Medical Image Database COW - Case of the Week Case Contributor: Hugh M Dainer Affiliation: National Capital Consortium.
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Colorectal Cancer Early detection of disease Precise Staging.
Integrated PET/CT in Differentiated Thyroid Cancer: Diagnostic Accuracy and Impact on Patient Management J Nucl Med 2006; 47:616–624 報告者 : 蘇惠怡.
Dual-time point 18F-FDG PET/CT scan: is it always working?
Thorax / Lung Basic Science Conference 12/21/2005 J.R. Nitzkorski.
MedPix Medical Image Database COW - Case of the Week Case Contributor: Jason Blitz Affiliation: Uniformed Services University.
Positron Emission Tomography (PET)
SYB Case 2 By: Amy. History 63 y/o female History of left breast infiltrating duct carcinoma s/p mastectomy in 1996 and chemotherapy ER negative, PR negative,
 Determining the Nature of a Breast Abnormality  It is a procedure that may be used to determine whether a lump is a cyst (sac containing fluid) or a.
PET Applications in Oncology
Chapter 28 Lung Cancer. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Objectives  Describe the epidemiology of.
Functional Imaging with PET for Sarcoma Rodney Hicks, MD, FRACP Director, Centre for Molecular Imaging Guy Toner, MD, FRACP Director, Medical Oncology.
PET in Colorectal Cancer. Indications for FDG PET Rising marker, (-) CT/MRI Nonspecific findings on CT/MRI, recurrence or post treatment changes? Known.
ACRIN 6685 Overview ACRIN 6685 A Multi-center Trial of FDG-PET/CT Staging of Head and Neck Cancer and its Impact on the N0 Neck Surgical Treatment in Head.
Follow up in Chest Tumors : Value of integrated PET/CT By : Dr. Heba Nabil, MSc Radiology Specialist at Nasser Institute For Research and Treatment.
11th Biennial Meeting of the International Gynecologic Cancer Society 11th Biennial Meeting of the International Gynecologic Cancer Society Semih Gorgulu,
NeoTect Tc99m Depreotide Injection. NeoTect  Approved by the FDA - August 3, 1999  Used in Imaging Pulmonary Masses  Normal activity in high concentrations.
Characteristic Dynamic Enhancement Pattern of MR imaging for Malignant Thyroid Tumor XIX Symposium Neuroradiologicum Division of Head & Neck radiology.
Nuclear Medicine and PET rev this is now slide 1do not print it to pdf things to do (check off when complete): add revision date to cover page.
Differential diagnosis of head and neck swellings
IMAGING OF INCIDENTAL ADRENAL LESIONS: PRINCIPLES, TECHNIQUES AND ALGORITHMS Giles W.L. Boland Massachusetts General Hospital Harvard Medical School.
Supraclavicular metastasis from urothelial bladder carcinoma: A case report S. Farmahan, T. Mirza, P. Ameerally Oral Maxillofacial Department, Northampton.
핵의학과 PK 18 조 68 번 주리히 Case presentation 2 Disease review 3 Journal review.
Date of download: 6/27/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Diagnostic Accuracy of Colorectal Cancer Staging.
Figure 1: a 32-year-old woman presented with RT breast mass, MRI showed false positive diagnosis of cancer. Dynamic contrast enhanced MRI, axial subtraction.
Bronchoscopy/ Endobronchial ultrasound
A prospective study of PET/CT in initial staging of small-cell lung cancer : comparison with CT, bone scintigraphy and bone marrow analysis B. M. Fischer1,
Metastatic Amelanotic Melanoma
FDG Squamous Cell Carcinoma of Tonsil
PET Applications in Oncology 2015/2016
CT and PET imaging in non-small cell lung cancer
Soft tissue sarcoma. Forty-eight-year-old morbidly obese woman with a painless rapidly enlarging left anterior thigh. (A) Lateral radiograph of the left.
Soft tissue sarcoma. Forty-eight-year-old morbidly obese woman with a painless rapidly enlarging left anterior thigh. (A) Lateral radiograph of the left.
Keith E. Kelly, MD and William H. Culbertson, MD
FDG PET-CT of Genitourinary and Gynecologic Tumors: Overcoming the Challenges of Evaluating the Abdomen and Pelvis  Leslie K. Lee, MD, Aoife Kilcoyne,
Radio Iodine Therapy In Cancer Thyroid
Erica V. Bloomquist, MD Heather Wright, MD
Michael Lin, Jenn Hian Koo, David Abi–Hanna 
Applications of Diagnostic Imaging Nuclear Medicine
Tc99m Depreotide Injection
Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease  Geoffrey M. Graeber, MD*, Naresh.
The impact of 18F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: Results from Westmead Hospital, Sydney, Australia  Rebecca.
MR-PET of the body: Early experience and insights
The role of positron emission tomography for non-small cell lung cancer  Albert J. Chang, MD, PhD, Farrokh Dehdashti, MD, Jeffrey D. Bradley, MD  Practical.
Figure 12a Pitfalls in N staging at CT and PET
Presentation transcript:

PET/CT: Improved Confidence in Imaging ? PET/CT: Improved Confidence in Imaging

Why PET/CT Improved diagnostic accuracy over PET or CT alone More Accurate Disease Staging More Accurate Surgical Planning More Accurate Guided Biopsy More Accurate Radiation Therapy Planning IMPROVED DIAGNOSTIC CONFIDENCE (for improved patient management)

History of Radiology and Cancer “50 Years of Imaging Form” Form = Anatomy Anatomy continues to be the cornerstone of cancer imaging for diagnosis, staging and follow up. Form has served us very well in X-Ray, US, CT, and MR MR CT

“Form” Strengths and Limitations Strengths …but Diagnostic Questions Remain Clear delineation of form What is normal? Performance is less post operative due to distortion of normal anatomy Accurate detection and What is the mass? (fat? water? air?) localization of masses Accurate detection of lymph What is within the lymph nodes? nodes (present or absent) (benign or malignant?) Some small lesion What is the cause? identification Have small tumor foci been over- looked (especially if surrounded by normal tissues)?

“Form” Strengths and Limitations Treatment Planning Questions Also Remain What will be the response to a particular therapy? What sort of tumor biology is present? Has there been a response (especially cytostatic) that I’m not seeing yet because it’s too soon for the “form” to reflect changes? PET (and PET/CT) address many of the limitations of anatomic imaging alone

“Function” Imaging – FDG-PET FDG-PET Strengths …but High sensitivity for detection of abnormal cell metabolism Real-time measurements of changes in disease state (and hence effectiveness of therapy) Powerful rotating display formats to aid in accurate interpretations based on human motion-oriented vision

“Function” Imaging – FDG-PET …but Questions Remain Where is the tracer uptake? Where should we biopsy? Where should we resect? Is the tracer uptake in tumor or non-malignant tissues (e.g. infection)?

Tough Questions CT shows infiltrates at both lung bases. Clearly abnormal. PET shows modest basilar lung FDG uptake? What is it?

What is PET/CT? Where Form meets Function A view into the body that allows us to see what it is happening and where. Hybrid Imaging Device/Modality Diagnostic CT scanner (high quality images of anatomy) PET scanner (high quality images of function) Computer and software to fuse/display images No patient motion between studies (or very little)

Where Form meets Function What is PET/CT? normal heart Where Form meets Function The best of detection and localization Better than PET or CT alone lung cancer

More Accurate Staging PET/CT Sensitivity to hyper-metabolism in normal-sized nodes on CT. Accurate spatial localization of abnormalities detected on PET, but difficult to localize.

More Accurate Staging NSCLC 5mm lymph node met No enlarged lymph nodes seen in the apex of the thorax on CT. Focal area of increased radionuclide uptake found on PET. Exact location remained unclear. PET/CT fused image matched hyper- metabolism to a normal-sized lymph node. Metastatic disease confirmed via histology. Chemotherapy initiated. Lardinois, et. al., NEJM 2003, 348:2500-07.

More Accurate Staging Breast cancer patient Malignant cell activity localized in a normal sized axillary lymph node. Disease overlooked on CT alone. Hao Vuong, MD, Baptist Hospital of Miami

More Accurate Surgical Planning Colorectal cancer patient PET/CT demonstrates a solitary met in the liver Upstages patient to Stage IV Hao Vuong, MD, Baptist Hospital of Miami Despite Stage IV, PET/CT indicates there is still a possibility of surgical cure, based on the localization of primary and metastatic activity.

More Accurate Guided Biopsy CT shows LUL mass consistent with Lung Cancer and no nodal metastases PET shows right paratracheal uptake suggesting nodal metastasis PET/CT shows metastasis to normal sized right paratracheal node Proven by biopsy.

More Accurate Guided Biopsy Head and Neck cancer patient PET/CT identifies a nasopharyngeal squamous cell carcinoma Confirms increased metabolic activity is localized in a bilateral lymph node. Patient therapy plan is changed from limited-field radiation treatment to a combined radiation/chemotherapeutic approach.

More Accurate RT Planning PET/CT is performed on a radiation therapy table to ensure consistent patient positioning. Fiducial markers are evident in the images. PET/CT images can be moved directly into radiation therapy planning workstations for seamless integreation of metabolic, anatomic, and irradiation planning information.

More Accurate RT Planning History 63 YOF, nasopharyngeal cancer 5 yrs prior Presents with progressive dysphagia and neck pain Panendoscopy negative, MRI unrevealing PET/CT Findings FDG accumulation in the posterior aspect of the larynx (SUV= 15.8) – not shown here Small focus with mild FDG uptake (SUV = 1.2) corresponding to a small lymph node in the left neck. Impact to Patient Management Deep biopsies confirmed squamous cell carcinoma, likely the development of a second primary head and neck cancer. Mild FDG uptake in the small node is likely to be metastatic. Radiation therapy was selected as the primary treatment. The PET/CT images were used in planning the radiation therapy. SUV = 1.2

Improved Confidence CT is clearly abnormal PET is mildly abnormal Bronchioloalveolar Carcinoma CT is clearly abnormal PET is mildly abnormal When combined: Worrisome for brochioloalveolar carcinoma Confirmed by biopsy

Characterization and Localization CT shows precise lesion size, shape and location PET shows increased FDG uptake Non-Small-Cell Lung Cancer

Confirmation of Benign Nodule CT shows pulmonary nodule which is large enough to image with PET PET shows no increased tracer uptake No disease present

Better than PET or CT alone Diagnostic Accuracy with Respect to Tumor Stage (40 Pts) Non-Small-Cell Lung Cancer Classification Correct but Imaging Method Correct Equivocal Incorrect CT alone 58% 20% 22% PET alone 40% 40% 20% Visual correlation of 65% 12% 22% PET and CT Integrated PET-CT 88% 10% 2% Lardinois, et. al., NEJM 2003, 348:2500-07

Better than PET or CT alone Diagnostic Accuracy with Respect to Node Stage (37 Pts) Non-Small-Cell Lung Cancer Classification Correct but Imaging Method Correct Equivocal Incorrect CT alone 59% 5% 35% PET alone 49% 38% 14% Visual correlation of 59% 11% 30% PET and CT Integrated PET-CT 81% 3% 16% Lardinois, et. al., NEJM 2003, 348:2500-07

Improved Certainty History of Melanoma What is Tumor? What is Not?

Normal Tissues with FDG Uptake Not everything using glucose is tumor. Anatomy can be helpful in making this separation. Example: Normal Head and Neck areas of increased FDG metabolism (Minimize by NOT talking during uptake nor swallowing) Tonsils Submandibular and Parotid Glands Cricoarytenoid muscles

Normal FDG-PET Map Parotids, Soft Palate, Spinal Cord Transaxial images of parotid glands (A, arrows), soft palate (A, arrowhead), spinal cord (A, small arrow), Parotids, Soft Palate, Spinal Cord

PET/CT: Faster Scan Time Much faster total scan time than PET alone (approx 20 minutes) CT provides 30 second transmission scans for the PET study vs 20 minute transmission scans with PET only devices 40-50% increased scan volume capacity Improved cost-effectiveness with improved productivity 20 min emission 20 min transmission 20 sec transmission PET Only PET/CT 40 min 20 min

Patient preparation Fasting for four hours Patient changed into gown and pants All metallic objects are removed Check glucose levels < 200 mg/dl 2 bottles of Readi-CAT (Barium sulphate 1.3 %) oral CT contrast prior to injection of 18F-FDG We switched to using oral contrast as of November of last year. Add barium concenrtration.

Patient Preparation PET Scan Preparation Fasting for 4 hours Patient changed into gown and pants All metallic objects are removed Check glucose levels (< 200 mg/dl) .22 mCi/kg FDG for whole body imaging (injected dose varies by scanner) 2D or 3D imaging of whole body (3D imaging of brain) CT Scan Preparation Patient is positioned head first and supine on the table Scanning begins from meatus of ear to mid thigh Shallow breathing during the CT Currently, non contrast CT is best choice for transmission images as arterial contrast can cause artifacts

Scan Protocols PET Scan Protocol 3-5 minute emission per FOV for Whole Body imaging 3 minute emission per FOV for Melanoma imaging (more FOVs) 10-20 minute emission for 3D brain imaging CT Scan Protocol Helical High Speed Pitch 6 22.5 mm/rotation 5 mm slices 140 kV & 80mA—varies 50 cm DFOV 512 x 512 matrix

PET/CT (Fusion) Workstations Fusion occurs on the PET/CT scanner workstation Hi-Res CT images are minimized to 128x128 matrix Images can be displayed in any plane or slice MIP (3D PET images) and CT Scout views are provided Entegra images here

Where Form meets Function PET is Very Accurate. PET/CT is even more Accurate. Disease Staging Surgical Planning Guided Biopsy Radiation Therapy Planning PET/CT Better than PET or CT alone Editor: Richard L. Wahl, M.D. Division of Nuclear Medicine Department of Radiology Johns Hopkins Medical Institutes Other Contributors: Hao Vuong Baptist Hospital of Miami Jack Ziffer Homer Macapinlac MD Anderson Cancer Center